|
1
|
Tolentino MJ: Current molecular
understanding and future treatment strategies for pathologic ocular
neovascularization. Curr Mol Med. 9:973–981. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang FH, Liang YB, Zhang F, et al:
Prevalence of diabetic retinopathy in rural China: the Handan Eye
Study. Ophthalmology. 116:461–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith LE, Wesolowski E, McLellan A, et al:
Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci.
35:101–111. 1994.PubMed/NCBI
|
|
4
|
Yu P, Passam FH, Yu DM, Denyer G and
Krilis SA: Beta2-glycoprotein I inhibits vascular endothelial
growth factor and basic fibroblast growth factor induced
angiogenesis through its amino terminal domain. J Thromb Haemost.
6:1215–1223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Laat B, van Berkel M, Urbanus RT, et
al: Immune responses against domain I of β(2)-glycoprotein I are
driven by conformational changes: domain I of β(2)-glycoprotein I
harbors a cryptic immunogenic epitope. Arthritis Rheum.
63:3960–3968. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Passam FH, Rahgozar S, Qi M, et al: Beta 2
glycoprotein I is a substrate of thiol oxidoreductases. Blood.
116:1995–1997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Passam FH, Rahgozar S, Qi M, et al: Redox
control of β2-glycoprotein I-von Willebrand factor interaction by
thioredoxin-1. J Thromb Haemost. 8:1754–1762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ioannou Y, Zhang JY, Passam FH, et al:
Naturally occurring free thiols within beta 2-glycoprotein I in
vivo: nitrosylation, redox modification by endothelial cells and
regulation of oxidative stress induced cell injury. Blood.
116:1961–1970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Passam FH, Qi JC, Tanaka K, Matthaei KI
and Krilis SA: In vivo modulation of angiogenesis by beta 2
glycoprotein I. J Autoimmun. 35:232–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Beecken WD, Engl T, Ringel EM, et al: An
endogenous inhibitor of angiogenesis derived from a transitional
cell carcinoma: clipped beta2-glycoprotein-I. Ann Surg Onco.
13:1241–1251. 2006. View Article : Google Scholar
|
|
11
|
Yoncopoulos GD, Davis S, Gale NW, Rudge
JS, Wiegand SJ and Holash J: Vascular-specific growth factors and
blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar
|
|
12
|
Yoshida S, Yoshida A and Ishibashi T:
Induction of IL-8, MCP-l, and bFGF by TNF-alpha in retinal glial
cells: implications for retinal neovascularization during
post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol.
242:409–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng Y, vom Hagen F, Pfister F, et al:
Impaired pericyte recruitment and abnormal retinal angiogenesis as
a result of angiopoietin-2 overexpression. Thromb Haemost.
97:99–108. 2007.PubMed/NCBI
|
|
14
|
Gardiner TA, Gibson DS, de Gooyer TE, de
la Cruz VF, McDonald DM and Stitt AW: Inhibition of tumor necrosis
factor-alpha improves physiological angiogenesis and reduces
pathological neovascularization in ischemic retinopathy. Am J
Pathol. 166:637–644. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang R, Zhou SJ, Li CJ, et al: C-reactive
protein/oxidised low-density lipoprotein/β2-glycoprotein I complex
promotes atherosclerosis in diabetic BALB/c mice via
p38mitogen-activated protein kinase signal pathway. Lipids Health
Dis. 12:422013. View Article : Google Scholar
|
|
16
|
Ljubimov AV, Caballero S, Aoki AM, Pinna
LA, Grant MB and Castellon R: Involvement of protein kinase CK2 in
angiogenesis and retinal neovascularization. Invest Ophthalmol Vis
Sci. 45:4583–4591. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uusitalo-Jarvinen H, Kurokawa T, Mueller
BM, Andrade-Gordon P, Friedlander M and Ruf W: Role of protease
activated receptor l and 2 signaling in hypoxia-induced
angiogenesis. Arterioscler Thromb Vasc Biol. 27:1456–1462. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiao H, Sonoda KH, Ikeda Y, et al:
Interleukin-18 regulates pathological intraocular
neovascularization. J Leukoc Biol. 81:1012–1021. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Z, Wang S, Sorenson CM and Sheibani N:
Attenuation of retinal vascular development and neovascularization
in transgenic mice over-expressing thrombospondin-l in the lens.
Dev Dyn. 235:1908–1920. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tchaikovski V, Olieslagers S, Böhmer FD
and Waltenberger J: Diabetes mellitus activates signal transduction
pathways resulting in vascular endothelial growth factor resistance
of human monocytes. Circulation. 120:150–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park JH, Lee JY, Shin DH, Jang KS, Kim HJ
and Kong G: Loss of Mel-18 induces tumor angiogenesis through
enhancing the activity and expression of HIF-1α mediated by the
PTEN/PI3K/Akt pathway. Oncogene. 30:4578–4589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Modi H, Li L, Chu S, Rossi J, Yee JK and
Bhatia R: Inhibition of Grb2 expression demonstrates an important
role in BCR-ABL-mediated MAPK activation and transformation of
primary human hematopoietic cells. Leukemia. 25:305–312. 2011.
View Article : Google Scholar :
|
|
23
|
Parikh N, Shuck RL, Nguyen TA, Herron A
and Donehower LA: Mouse tissues that undergo neoplastic progression
after K-Ras activation are distinguished by nuclear translocation
of phospho-Erk1/2 and robust tumor suppressor responses. Mol Cancer
Res. 10:845–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taylor SM, Nevis KR, Park HL, et al:
Angiogenic factor signaling regulates centrosome duplication in
endothelial cells of developing blood vessels. Blood.
116:3108–3117. 2010. View Article : Google Scholar : PubMed/NCBI
|
